IM Cannabis Corp (IMCC) reports significant revenue growth in Germany, despite facing challenges in other markets and ...

The Inter-Ministerial Coordinating Committee (IMCC) on Decentralisation Secretariat convened the maiden meeting of the ...

Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ETCompany ParticipantsAnna Taranko - Director of Investor and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts estimate that IM Cannabis will report an earnings per share (EPS) of $-0.39. The market awaits IM Cannabis's ...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and ...

IM Cannabis Corp. (IMCC) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago. These figures are ...

IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased ...

The company still saw operational improvements in 2024, seeing positive adjusted EBITDA and sales growth in its German ...

(NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5. ...